Innovative Drugs to Treat Depression: Did Animal Models Fail to Be Predictive or Did Clinical Trials Fail to Detect Effects?
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Innovative Drugs to Treat Depression: Did Animal Models Fail to Be Predictive or Did Clinical Trials Fail to Detect Effects?
Authors
Keywords
-
Journal
NEUROPSYCHOPHARMACOLOGY
Volume 39, Issue 5, Pages 1041-1051
Publisher
Springer Nature
Online
2013-12-18
DOI
10.1038/npp.2013.342
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 50 years of hurdles and hope in anxiolytic drug discovery
- (2013) Guy Griebel et al. NATURE REVIEWS DRUG DISCOVERY
- Anti-depressive effect of polyphenols and omega-3 fatty acid from pomegranate peel and flax seed in mice exposed to chronic mild stress
- (2013) Shivanna Naveen et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- The CRF1 receptor antagonist SSR125543 prevents stress-induced cognitive deficit associated with hippocampal dysfunction: Comparison with paroxetine and d-cycloserine
- (2013) J. Philbert et al. PSYCHOPHARMACOLOGY
- Increased corticosterone in peripubertal rats leads to long-lasting alterations in social exploration and aggression
- (2013) Vandana Veenit et al. Frontiers in Behavioral Neuroscience
- Targeting the Glutamatergic System to Treat Major Depressive Disorder
- (2012) Daniel C. Mathews et al. DRUGS
- The Vasopressin V1bReceptor Antagonist SSR149415 in the Treatment of Major Depressive and Generalized Anxiety Disorders
- (2012) Guy Griebel et al. JOURNAL OF CLINICAL PSYCHIATRY
- Examination of Org 26576, an AMPA receptor positive allosteric modulator, in patients diagnosed with major depressive disorder: an exploratory, randomized, double-blind, placebo-controlled trial
- (2012) Kari R Nations et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning?
- (2012) Guy Griebel et al. NATURE REVIEWS DRUG DISCOVERY
- Lithium augmentation of the effects of desipramine in a mouse model of treatment-resistant depression: A role for hippocampal cell proliferation
- (2012) O.F. O’Leary et al. NEUROSCIENCE
- The neurobiology of depression and antidepressant action
- (2012) Paul Willner et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Deep brain stimulation in treatment-resistant depression in mice: Comparison with the CRF1 antagonist, SSR125543
- (2012) Carine Dournes et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Depressive and cardiovascular disease comorbidity in a rat model of social stress: a putative role for corticotropin-releasing factor
- (2012) Susan K. Wood et al. PSYCHOPHARMACOLOGY
- ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression
- (2012) A B Singh et al. Translational Psychiatry
- A Double-Blind Placebo-Controlled Trial of Lamotrigine as an Antidepressant Augmentation Agent in Treatment-Refractory Unipolar Depression
- (2011) James G. Barbee et al. JOURNAL OF CLINICAL PSYCHIATRY
- Discovering imaging endophenotypes for major depression
- (2011) G Hasler et al. MOLECULAR PSYCHIATRY
- Antidepressants recruit new neurons to improve stress response regulation
- (2011) A Surget et al. MOLECULAR PSYCHIATRY
- Is there still a future for neurokinin 3 receptor antagonists as potential drugs for the treatment of psychiatric diseases?
- (2011) Guy Griebel et al. PHARMACOLOGY & THERAPEUTICS
- Results of a proof-of-concept, dose-finding, double-blind, placebo-controlled study of RX-10100 (Serdaxin®) in subjects with major depressive disorder
- (2011) Robert Riesenberg et al. PSYCHOPHARMACOLOGY
- Chronic ω-3 fatty acids supplementation promotes beneficial effects on anxiety, cognitive and depressive-like behaviors in rats subjected to a restraint stress protocol
- (2010) Anete Curte Ferraz et al. BEHAVIOURAL BRAIN RESEARCH
- Open questions in current models of antidepressant action
- (2010) A Tanti et al. BRITISH JOURNAL OF PHARMACOLOGY
- Antidepressant Drug Effects and Depression Severity
- (2010) Jay C. Fournier et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Eicosapentaenoic acid as an add-on to antidepressant medication for co-morbid major depression in patients with diabetes mellitus: A randomized, double-blind placebo-controlled study
- (2010) M. Bot et al. JOURNAL OF AFFECTIVE DISORDERS
- The Efficacy of Omega-3 Supplementation for Major Depression
- (2010) François Lespérance et al. JOURNAL OF CLINICAL PSYCHIATRY
- Omega-3 fatty acids for major depressive disorder associated with the menopausal transition
- (2010) Marlene P. Freeman et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Neuropsychiatric Disorders in Cushing’s Syndrome
- (2010) Alberto M. Pereira et al. NEUROENDOCRINOLOGY
- ABCB1 (MDR1) polymorphisms and antidepressant response in geriatric depression
- (2010) Jane E. Sarginson et al. Pharmacogenetics and Genomics
- CYP2C19 variation and citalopram response
- (2010) David A. Mrazek et al. Pharmacogenetics and Genomics
- Therapeutic utility of non-peptidic CRF1 receptor antagonists in anxiety, depression, and stress-related disorders: Evidence from animal models
- (2010) John H. Kehne et al. PHARMACOLOGY & THERAPEUTICS
- Association between Repeated Unpredictable Chronic Mild Stress (UCMS) Procedures with a High Fat Diet: A Model of Fluoxetine Resistance in Mice
- (2010) Elsa Isingrini et al. PLoS One
- A Molecular Signature of Depression in the Amygdala
- (2009) Etienne Sibille et al. AMERICAN JOURNAL OF PSYCHIATRY
- Tachykinin Receptors as Therapeutic Targets in Stress-Related Disorders
- (2009) Karl Ebner et al. CURRENT PHARMACEUTICAL DESIGN
- Neurogenesis-Dependent and -Independent Effects of Fluoxetine in an Animal Model of Anxiety/Depression
- (2009) Denis J. David et al. NEURON
- Subchronic Alpha-Linolenic Acid Treatment Enhances Brain Plasticity and Exerts an Antidepressant Effect: A Versatile Potential Therapy for Stroke
- (2009) Nicolas Blondeau et al. NEUROPSYCHOPHARMACOLOGY
- Drug-Dependent Requirement of Hippocampal Neurogenesis in a Model of Depression and of Antidepressant Reversal
- (2008) Alexandre Surget et al. BIOLOGICAL PSYCHIATRY
- Chronic stress-induced alterations in amygdala responsiveness and behavior - modulation by trait anxiety and corticotropin-releasing factor systems
- (2008) Carmen Sandi et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Depression in Parkinson's disease: A double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation
- (2008) Ticyana Moralez da Silva et al. JOURNAL OF AFFECTIVE DISORDERS
- Humanized Mouse Lines and Their Application for Prediction of Human Drug Metabolism and Toxicological Risk Assessment
- (2008) C. Cheung et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling
- (2008) J M Bessa et al. MOLECULAR PSYCHIATRY
- The molecular neurobiology of depression
- (2008) Vaishnav Krishnan et al. NATURE
- SSR149415, a non-peptide vasopressin V1b receptor antagonist, has long-lasting antidepressant effects in the olfactory bulbectomy-induced hyperactivity depression model
- (2008) M. E. Breuer et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Polymorphisms in the Drug Transporter Gene ABCB1 Predict Antidepressant Treatment Response in Depression
- (2008) Manfred Uhr et al. NEURON
- Removing Obstacles in Neuroscience Drug Discovery: The Future Path for Animal Models
- (2008) Athina Markou et al. NEUROPSYCHOPHARMACOLOGY
- Corticolimbic Transcriptome Changes are State-Dependent and Region-Specific in a Rodent Model of Depression and of Antidepressant Reversal
- (2008) Alexandre Surget et al. NEUROPSYCHOPHARMACOLOGY
- PUFA induce antidepressant-like effects in parallel to structural and molecular changes in the hippocampus
- (2008) Venugopal Reddy Venna et al. PSYCHONEUROENDOCRINOLOGY
- Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration
- (2008) Irving Kirsch et al. PLOS MEDICINE
- Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms
- (2007) Yvonne Freund-Levi et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Additional evidence for anxiolytic- and antidepressant-like activities of saredutant (SR48968), an antagonist at the neurokinin-2 receptor in various rodent-models
- (2007) Caroline Louis et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder
- (2007) Masaki Kato et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation